News Bayer slides on €9.5bn loss caused by litigation, COVID-19 i... Bayer counted the cost of its expensive Roundup weedkiller settlement in the second quarter with a €9.5 billion net loss made worse by lower sales in its pharma and consumer he
News BI opens second branch of digital lab in China Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in July this year in China.
Views & Analysis Does pharma’s future lie in China? Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders.
News Vifor forges iron drug partnership with Fresenius in China Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.
Views & Analysis Nine pharma trends for 2020 Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.